Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment

Table 4 Dietary intake in study subjects

Dietary intake	Reference value	Non-MTX users (n = 32)	MTX users (n = 67)	Pvalue^a
Energy, kcal/day	2,000	1,248 (1,158 to 1,507)	1,249 (1,184 to 1,419)	0.862
Carbohydrate, g/day	300	183.5 (155.9 to 275.2)	174.5 (174.2 to 216.9)	0.994
Percentage of energy	60%	58.65%	55.94%
Protein, g/day	(50)	51.1 (19.9 to 141.0)	38.9 (38.3 to 45.8)	0.849
Percentage of energy	10%	16.39%	12.48%
Fat, g/day	(65)	43.9 (11.0 to 133.8)	38.6 (36.2 to 45.0)	0.505
Percentage of energy	<30%	31.68%	27.88%
Cholesterol, mg/day	(<300)	243.8 (109.4 to 178.4)	223.6 (77.1 to 516.1)	0.493

Results are expressed as median (95%CI) (n = 99).
^aData were compared between methotrexate MTX- and MTX+ subjects by Mann-Whitney U test.

ISSN: 1741-7015